Literature DB >> 10465049

Antibody isotype responses, infection and re-infection for Schistosoma japonicum in a marshland area of China.

Y S Li1, A G Ross, A C Sleigh, Y Li, G J Waine, G J Williams, M Tanner, D P McManus.   

Abstract

Antibody isotype responses to adult worm antigen (AWA) of Schistosoma japonicum and two recombinant proteins (paramyosin (PMY) and a 22 kDa tegumental membrane-associated antigen (TEG)) were analyzed in 137 individuals from an area moderately endemic for schistosomiasis in the Dongting Lake region, Hunan Province, China. The prevalence and geometric mean (GM) intensity of infection before the implementation of curative chemotherapy were 28.5% and 234.4 epg, respectively, but 9 months after treatment the prevalence (6.6%) and intensity (38.3 epg) had decreased. There was no significant difference in either the prevalence or intensity of infection between males and females. Specific IgG (total), IgG4, IgG2, IgA and IgE responses to AWA, PMY and TEG were measured by ELISA. Males produced significantly (P < 0.05) more anti-AWA total IgG, IgE, IgA, IgG4 and IgG2 antibodies, and anti-TEG IgG2 antibody than their female counterparts. The OD450 levels of anti-AWA, PMY and TEG antibody isotypes did not present clear age-dependent trends except for peak levels of anti-AWA IgG4 antibodies evident among subjects 20-29 years of age. The total IgG and IgG4 antibody profiles against AWA correlated well with current S. japonicum infections while anti-AWA IgG2, IgA and IgE antibodies did not show such an association. Anti-AWA-specific IgE antibody levels were positively correlated (r = 0.55) with anti-AWA specific IgG4 antibody levels. In addition, the overall percentage of responders (using a cut-off value obtained from normal controls) to all isotypes to AWA were higher than those observed for both the recombinant antigens. Only 18.2%, 16.8% and 7.3% of the study population were IgE responders to AWA, PMY and TEG. A longer follow-up period is required before we can more fully understand the role of IgE, if any, in protective immunity against schistosomiasis japonica.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10465049     DOI: 10.1016/s0001-706x(99)00019-4

Source DB:  PubMed          Journal:  Acta Trop        ISSN: 0001-706X            Impact factor:   3.112


  10 in total

1.  Comparative analysis of the diagnostic performance of adult, cercarial and egg antigens assessed by ELISA, in the diagnosis of chronic human Schistosoma mansoni infection.

Authors:  Rania Mohammad Sarhan; Heba AbdelKader Aminou; Ghada Abdel Rahman Saad; Ossama Ashraf Ahmed
Journal:  Parasitol Res       Date:  2014-07-16       Impact factor: 2.289

2.  Utility of Schistosoma bovis adult worm antigens for diagnosis of human schistosomiasis by enzyme-linked immunosorbent assay and electroimmunotransfer blot techniques.

Authors:  J Pardo; C Carranza; M C Turrientes; J L Pérez Arellano; R López Vélez; V Ramajo; A Muro
Journal:  Clin Diagn Lab Immunol       Date:  2004-11

3.  Down-regulation of specific antigen-driven cytokine production in a population with endemic Schistosoma japonicum infection.

Authors:  L Shen; Z S Zhang; H W Wu; R E Weir; Z W Xie; L S Hu; S Z Chen; M J Ji; C Su; Y Zhang; Q D Bickle; S N Cousens; M G Taylor; G L Wu
Journal:  Clin Exp Immunol       Date:  2002-08       Impact factor: 4.330

4.  Development of a specimen-sparing multichannel bead assay to detect antiparasite IgG4 for the diagnosis of Schistosoma and Wuchereria infections on the coast of Kenya.

Authors:  Adam S DuVall; Jessica K Fairley; Laura Sutherland; Amaya L Bustinduy; Peter L Mungai; Eric M Muchiri; Indu Malhotra; Uriel Kitron; Charles H King
Journal:  Am J Trop Med Hyg       Date:  2014-02-10       Impact factor: 2.345

5.  Partial regulatory T cell depletion prior to schistosomiasis vaccination does not enhance the protection.

Authors:  Xuefeng Wang; Fan Liu; Sha Zhou; Zhipeng Xu; Jason Hoellwarth; Xiaojun Chen; Lei He; Rongbo Zhang; Feng Liu; Jun Wang; Chuan Su
Journal:  PLoS One       Date:  2012-07-03       Impact factor: 3.240

6.  Identification and profiling of circulating antigens by screening with the sera from schistosomiasis japonica patients.

Authors:  Yan Lu; Bin Xu; Chuan Ju; Xiaojin Mo; Shenbo Chen; Zheng Feng; Xiaoning Wang; Wei Hu
Journal:  Parasit Vectors       Date:  2012-06-11       Impact factor: 3.876

7.  The nature and combination of subunits used in epitope-based Schistosoma japonicum vaccine formulations affect their efficacy.

Authors:  Xuefeng Wang; Lei Zhang; Ying Chi; Jason Hoellwarth; Sha Zhou; Xiaoyun Wen; Lei He; Feng Liu; Calvin Wu; Chuan Su
Journal:  Parasit Vectors       Date:  2010-11-19       Impact factor: 3.876

8.  Dynamics of Th17 cells and their role in Schistosoma japonicum infection in C57BL/6 mice.

Authors:  Xiaoyun Wen; Lei He; Ying Chi; Sha Zhou; Jason Hoellwarth; Cui Zhang; Jifeng Zhu; Calvin Wu; Shawn Dhesi; Xuefeng Wang; Feng Liu; Chuan Su
Journal:  PLoS Negl Trop Dis       Date:  2011-11-15

9.  An association of Aquaporin-4 with the immunoregulation of liver pathology in mice infected with Schistosoma japonicum.

Authors:  Weiwei Zhang; Jifeng Zhu; Xian Song; Zhipeng Xu; Xue Xue; Xiaojun Chen; Xiaowei Yang; Yong Li; Xiaoxiao Dong; Sha Zhou; Wei Li; Yingying Qian; Feng Liu; Chuan Su
Journal:  Parasit Vectors       Date:  2015-01-21       Impact factor: 3.876

10.  sTNFR-II and sICAM-1 are associated with acute disease and hepatic inflammation in schistosomiasis japonica.

Authors:  Magda K Ellis; Yuesheng Li; Xunya Hou; Honggen Chen; Donald P McManus
Journal:  Int J Parasitol       Date:  2007-10-12       Impact factor: 3.981

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.